The Lewis A phenotype is a restriction factor for Rotateq and Rotarix vaccine-take in Nicaraguan children

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Bucardo, Filemón ^a   Nordgren, Johan ^b   Reyes, Yaoska ^a   Gonzalez, Fredman ^a   Sharma, Sumit ^b   Svensson, Lennart ^b,c  

^a Universidad Nacional Autónoma de Nicaragua   (Nicaragua)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; LIVE VACCINE; RIX4414 VACCINE; ROTAVIRUS VACCINE; VIRUS ANTIBODY;

BLOOD; BLOOD GROUP LEWIS SYSTEM; CHILD; GENOTYPE; HUMAN; IMMUNOLOGY; NICARAGUA; PROSPECTIVE STUDY; SEROCONVERSION; TREATMENT OUTCOME;

ANTIBODIES, VIRAL; CHILD; GENOTYPE; HUMANS; IMMUNOGLOBULIN A; LEWIS BLOOD-GROUP SYSTEM; NICARAGUA; PROSPECTIVE STUDIES; ROTAVIRUS VACCINES; SEROCONVERSION; TREATMENT OUTCOME; VACCINES, ATTENUATED;

EID: 85041057588     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-19718-y     Document Type: Article

References (46)

1. Jiang, V., Jiang, B., Tate, J., Parashar, U. D. & Patel, M. M. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin 6, 532-542 (2010).
2. Armah, G. E. et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376, 606-614 (2010).
3. Madhi, S. A. et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362, 289-298 (2010).
4. Isanaka, S. et al. Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger. N Engl J Med 376, 1121-1130 (2017).
5. Patel, M. et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 301, 2243-2251 (2009).
6. Kandasamy, S., Chattha, K. S., Vlasova, A. N. & Saif, L. J. Prenatal vitamin A deficiency impairs adaptive immune responses to pentavalent rotavirus vaccine (RotaTeq(R)) in a neonatal gnotobiotic pig model. Vaccine 32, 816-824 (2014).
7. Patel, M., Steele, A. D. & Parashar, U. D. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines. Vaccine 30(Suppl 1), A30-35 (2012).
8. Taniuchi, M. et al. Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants. Vaccine 34, 3068-3075 (2016).
9. Moon, S. S. et al. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants. Clin Infect Dis 62, 157-165 (2016).
10. Naylor, C. et al. Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh. EBioMedicine 2, 1759-1766 (2015).
11. Harris, V. C. et al. Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana. J Infect Dis 215, 34-41 (2017).
12. Nordgren, J. et al. Both lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin Infect Dis 59, 1567-1573 (2014).
13. Nordgren, J., Sharma, S., Kambhampati, A., Lopman, B. & Svensson, L. Innate Resistance and Susceptibility to Norovirus Infection. PLoS Pathog 12, e1005385 (2016).
14. Ramani, S., Hu, L., Venkataram Prasad, B. V. & Estes, M. K. Diversity in Rotavirus-Host Glycan Interactions: A "Sweet" Spectrum. Cell Mol Gastroenterol Hepatol 2, 263-273 (2016).
15. Torrado, J. et al. Lewis, secretor, and ABO phenotypes, and sulfomucin expression in gastric intestinal metaplasia. Cancer Epidemiol Biomarkers Prev 6, (287-289 (1997).
16. Serpa, J. et al. Lewis enzyme (alpha1-3/4 fucosyltransferase) polymorphisms do not explain the Lewis phenotype in the gastric mucosa of a Portuguese population. J Hum Genet 48, 183-189 (2003).
17. Larsson, M. M. et al. Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis 194, 1422-1427 (2006).
18. Bucardo, F. et al. Genetic susceptibility to symptomatic norovirus infection in Nicaragua. J Med Virol 81, 728-735 (2009).
19. Nordgren, J., Nitiema, L. W., Ouermi, D., Simpore, J. & Svensson, L. Host genetic factors affect susceptibility to norovirus infections in Burkina Faso. PLoS One 8, e69557 (2013).
20. Corvelo, T. C. et al. The Lewis histo-blood group system: molecular analysis of the 59T > G, 508G > A, and 1067T > A polymorphisms in an Amazonian population. PLoS One 8, e69908 (2013).
21. Agocs, M. M. et al. WHO global rotavirus surveillance network: a strategic review of the first 5 years, 2008-2012. MMWR Morb Mortal Wkly Rep 63, 634-637 (2014).
22. Bernstein, D. I. et al. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial. Lancet 354, 287-290 (1999).
23. Matthijnssens, J. et al. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 403, 111-127 (2010).
24. Espinoza, F., Paniagua, M., Hallander, H., Svensson, L. & Strannegard, O. Rotavirus infections in young Nicaraguan children. Pediatr Infect Dis J 16, 564-571 (1997).
25. Kazi, A. M. et al. Secretor and Salivary ABO Blood Group Antigen Status Predict Rotavirus Vaccine Take in Infants. J Infect Dis 215, 786-789 (2017).
26. Becker-Dreps, S. et al. Rotavirus-specific IgG antibodies from mothers' serum may inhibit infant immune responses to the pentavalent rotavirus vaccine. Pediatr Infect Dis J 34, 115-116 (2015).
27. Imbert-Marcille, B. M. et al. A FUT2 Gene Common Polymorphism Determines Resistance to Rotavirus A of the P[8] Genotype. J Infect Dis, (2013).
28. Van Trang, N. et al. Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. Journal of clinical microbiology 52, 1366-1374 (2014).
29. Zhang, X. F. et al. P[8] and P[4] Rotavirus Infection Associated with Secretor Phenotypes Among Children in South China. Sci Rep 6, 34591 (2016).
30. Payne, D. C. et al. Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. JAMA Pediatr 169, 1040-1045 (2015).
31. Sun, X. et al. Binding specificity of P[8] VP8∗ proteins of rotavirus vaccine strains with histo-blood group antigens. Virology 495, 129-135 (2016).
32. Huang, P. et al. Spike Protein VP8∗ of Human Rotavirus Recognizes Histo-Blood Group Antigens in a Type-Specific Manner. J Virol 86, 4833-4843 (2012).
33. Ma, X. et al. Binding Patterns of Rotavirus Genotypes P[4], P[6], and P[8] in China with Histo-Blood Group Antigens. PLoS One 10, e0134584 (2015).
34. Elnady, H. G. et al. ABO blood grouping in Egyptian children with rotavirus gastroenteritis. Prz Gastroenterol 12, 175-180 (2017).
35. Johansen, K. & Svensson, L. Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA. Arch Virol 142, 1491-1498 (1997).
36. Becker-Dreps, S. et al. The Association Between Fecal Biomarkers of Environmental Enteropathy and Rotavirus Vaccine Response in Nicaraguan Infants. Pediatr Infect Dis J, (2016).
37. Espinoza, F. et al. Shifts of rotavirus g and p types in Nicaragua-2001-2003. Pediatr Infect Dis J 25, 1078-1080 (2006).
38. Das, B. K. et al. Characterization of rotavirus strains from newborns in New Delhi, India. Journal of clinical microbiology 32, 1820-1822 (1994).
39. Steele, D., Reynecke, E., de Beer, M., Bos, P. & Smuts, I. Characterization of rotavirus infection in a hospital neonatal unit in Pretoria, South Africa. J Trop Pediatr 48, 167-171 (2002).
40. Linhares, A. C. et al. Neonatal rotavirus infection in Belem, northern Brazil: nosocomial transmission of a P[6] G2 strain. J Med Virol 67, 418-426 (2002).
41. Ghosh, S., Urushibara, N., Chawla-Sarkar, M., Krishnan, T. & Kobayashi, N. Whole genomic analyses of asymptomatic human G1P[6], G2P[6] and G3P[6] rotavirus strains reveal intergenogroup reassortment events and genome segments of artiodactyl origin. Infect Genet Evol 16, 165-173 (2013).
42. Ameno, S. et al. Lewis and Secretor gene effects on Lewis antigen and postnatal development of Lewis blood type. Biol Neonate 79, 91-96 (2001).
43. Bautista-Marquez, A. et al. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix(R) immunization in Mexican infants. Vaccine 34, 5284-5289 (2016).
44. Chilengi, R. et al. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants. PLoS One 11, e0150100 (2016).
45. Bernstein, D. I., McNeal, M. M., Schiff, G. M. & Ward, R. L. Induction and persistence of local rotavirus antibodies in relation to serum antibodies. J Med Virol 28, 90-95 (1989).
46. Bucardo, F. et al. Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua. Clin Microbiol Infect 21(603), e601-607 (2015).